Suppr超能文献

抗菌肽piscidin-1非极性面中心的异亮氨酸被赖氨酸取代后,杀菌活性的速度加快,毒性降低。

Substitution of lysine for isoleucine at the center of the nonpolar face of the antimicrobial peptide, piscidin-1, leads to an increase in the rapidity of bactericidal activity and a reduction in toxicity.

作者信息

Taheri Behrouz, Mohammadi Mohsen, Momenzadeh Niloofar, Farshadzadeh Zahra, Roozbehani Mona, Dehghani Parva, Hajian Sobhan, Darvishi Sadegh, Shamseddin Jebreil

机构信息

Department of Medical Laboratory Sciences, School of Paramedicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

出版信息

Infect Drug Resist. 2019 Jun 14;12:1629-1647. doi: 10.2147/IDR.S195872. eCollection 2019.

Abstract

Piscidin-1 is an effective antimicrobial peptide (AMP) against a variety of microbes. However, its toxicity has been reported as a limitation for its potential therapeutic applications. The toxicity of piscidin-1 may be related to the long nonpolar face of this AMP. Here, we investigated different piscidin-1 analogs to reach a peptide with the reduced toxicity. In vitro and in vivo antibacterial activity and toxicity of piscidin-1 analogs generated by replacement of isoleucine at the border (I9) or the center (I16) of the nonpolar face of piscidin-1 by alanine or lysine were investigated. The results indicated that among all peptides, piscidin-1 with the highest HPLC retention time (RT) and I16K-piscidin-1 with the lowest RT had the highest and lowest cytotoxicity, respectively. Although I16K-piscidin-1 possessed the same MIC value as the parent peptide (piscidin-1) and other analogs, I16K-piscidin-1 exhibited a higher rapidity of bactericidal action at 5×MIC. The β-galactosidase leakage and propidium iodide staining assays indicated a higher pore-forming capacity of I16K-piscidin-1 relative to the parent peptide (piscidin-1). Taken together, RT is suggested to have a direct association with the toxicity and an inverse association with the rapidity of bactericidal action and pore-forming capacity. After infection of mice with clinical colistin-resistant or clinical methicillin-resistant strains, treatment with I16K-piscidin-1, but not piscidin-1 and other analogs, resulted in a significantly stronger bactericidal potency. Furthermore, I16K-piscidin-1 exhibited the lowest in vivo toxicity.  Overall, in vitro and in vivo comparison of piscidin-1 and its analogs together documented that replacement of isoleucine at the center of the nonpolar face of piscidin-1(I16) by lysine leads to not only a decrease in toxicity potential but also an increase in bactericidal potential.

摘要

杀鱼菌素-1是一种对多种微生物有效的抗菌肽(AMP)。然而,据报道其毒性是其潜在治疗应用的一个限制因素。杀鱼菌素-1的毒性可能与其该抗菌肽的长非极性面有关。在此,我们研究了不同的杀鱼菌素-1类似物,以获得一种毒性降低的肽。研究了通过用丙氨酸或赖氨酸取代杀鱼菌素-1非极性面边界(I9)或中心(I16)的异亮氨酸所产生的杀鱼菌素-1类似物的体外和体内抗菌活性及毒性。结果表明,在所有肽中,高效液相色谱保留时间(RT)最高的杀鱼菌素-1和RT最低的I16K-杀鱼菌素-1分别具有最高和最低的细胞毒性。尽管I16K-杀鱼菌素-1与亲本肽(杀鱼菌素-1)及其他类似物具有相同的最低抑菌浓度(MIC)值,但I16K-杀鱼菌素-1在5倍MIC时表现出更高的杀菌作用速度。β-半乳糖苷酶泄漏和碘化丙啶染色试验表明,I16K-杀鱼菌素-1相对于亲本肽(杀鱼菌素-1)具有更高的成孔能力。综上所述,提示RT与毒性直接相关,与杀菌作用速度和成孔能力呈负相关。在用临床耐黏菌素或临床耐甲氧西林菌株感染小鼠后,用I16K-杀鱼菌素-1而非杀鱼菌素-1及其他类似物治疗,产生了显著更强的杀菌效力。此外,I16K-杀鱼菌素-1表现出最低的体内毒性。总体而言,杀鱼菌素-1及其类似物的体外和体内比较共同证明,用赖氨酸取代杀鱼菌素-1非极性面中心的异亮氨酸(I16)不仅导致潜在毒性降低,而且杀菌潜力增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4453/6585414/c6b6f4ed29d2/IDR_A_195872_O_SF0001g.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验